Just an FYI about possible funding resources for Indigenous students from OR tribes! The Oregon Tribal Student Grant provides full funding for students who are enrolled members of any of the 9 federally recognized tribes in Oregon. Deadline for winter term funding: Nov. 1st!

Applications are Still Being Accepted for the Oregon Tribal Student Grant 

The HECC Office of Student Access  and Completion will continue to accept and review applications for the Oregon Tribal Student Grant for 2022-23 until funds are exhausted. Students planning to attend college in the 2022-23 academic  year, including fall term, are encouraged to apply.  The Oregon Tribal Student Grant is expected to pay for most or all public undergraduate college-related expenses—including tuition, housing, books, and other costs not covered by other grants—for eligible students who are enrolled members of Oregon’s nine federally recognized Tribes. Current and prospective students can learn more and apply here. The direct link to the Oregon Tribal Student Grant web page is: https://oregonstudentaid.gov/grants/oregon-tribal-student-grant/ 

Hello all.

We’re excited to be kicking off Gallo Winery’s 2023 intern recruiting efforts. I’m reaching out to let you know about the internship opportunities for the 2023 harvest season and to ask that you please share this information with your students. We look forward to having some OSU students/alumni for our 2023 harvest season!

Our internship job descriptions can be found via the TinyUrls below, on Handshake, or at https://www.gallocareers.com/. All current Gallo employment opportunities are available at  https://www.gallocareers.com/

2022-2023 Program2022-2023 Tiny URL2022-2023 Handshake Job ID
Winemaking & Spirits Distillation Internshiphttps://tinyurl.com/CVWMDist20237082337
Chemistry & Systems Biology Internshiphttps://tinyurl.com/CVChemBio20237082394
Grape Production & Viticulture Internshiphttps://tinyurl.com/CVVit20237082477
Premium Coastal Winemaking Internship7071239
Coastal Laboratory Internship7074234

Our Talent Acquisition team has suggested that we recruit in the fall to get the best students for our internships. Offers will be extended as we meet qualified applicants. Therefore, we encourage students to apply early while the maximum number of internships are available.

We will be on-campus to present on our 2023 internship opportunities at the Food and Fermentation Science Club meeting on November 9th. That event will be held in the Wiegand Hall Auditorium (115) from 5-6pm. I’ve attached a flyer for that event. Please share this with your students.  We will follow-up with Meet & Greets on November 10th in Wiegand Hall. Folks interested in learning more about our internships and/or Gallo opportunities in general can sign up to meet with our on-campus recruiting team. Sign-ups can be made through Calendly or please contact Deborah Gould (Deborah.Gould@oregonstate.edu). The Food Science and Technology Department has graciously provided rooms for these events, yet we hope to see students from various majors.

Please let me know if you or the students have questions. 

Thank you!

Cyd Yonker

Director – Enology Research

Winegrowing Research

E & J Gallo Winery

707-431-5532 (Office)

209-605-0453 (Mobile)

CBEE Fall Seminar Series
Monday, Oct. 24, 2022
4:00 PM – 5:00 PM

Owen 106
Katherine A. Mirica

Katherine was born and raised in Ukraine and emigrated with her family to the United States as she was starting high school. She obtained her B.S. in Chemistry at Boston College, where she developed a passion for Materials Chemistry, working in the laboratory of Lawrence T. Scott. She earned her Ph.D. in Chemistry from Harvard University under the guidance of George M. Whitesides and completed her postdoctoral training with Timothy M. Swager at the Massachusetts Institute of Technology. Katherine began her independent scientific career as an Assistant Professor in the Department of
Chemistry at Dartmouth College in July 2015 and was promoted to Associate Professor with tenure in 2021. Her research interests span the topics of self-assembly, design and synthesis of multifunctional
framework materials, electroanalysis, energy, catalysis, and adhesion science.

“Molecular Engineering of Conductive Framework Materials for Chemical Sensing”
Molecular engineering of new materials holds promise for improving human health, safety,
efficiency, and quality of life. This presentation will describe strategies for molecular
engineering of conductive, stimuli-responsive, and molecularly precise materials. The
presentation will describe several approaches for design, synthesis, and device integration of
two-dimensional (2D) conductive metal–organic frameworks (MOFs) and covalent organic
frameworks (COFs) to create devices with promising utility in electroanalysis. An emphasis will
be placed on the fundamental understanding and molecular design of modular
structure–property relationships within this class of 2D materials. In summary, this
presentation will demonstrate how molecular-level features within solid state materials can be
used to tune their stimuli-responsive function.

Jim Clarke

Director of Quantum Hardware, Intel Labs

Presenting on:

From a Grain of Sand to a (Quantum) Bit of Information

Monday, Nov 21st, 2022 ● 4:00 – 4:50pm ● DEAR 118


A large scale quantum computer could change the world.  Performing certain calculations in minutes that would take the largest supercomputer millions of years.  The impact to applications such as cryptography, chemistry, finance, etc would be huge. Today’s quantum processors are limited to 10’s of entangled quantum bits.   If you believe the hype, a commercially relevant system is just around the corner that can outperform our largest supercomputers for useful calculations.   The reality, however, is that we are still early in the race.    There are many unanswered fundamental questions.   At Intel, our approach is to rely on the continued evolution of Moore’s Law to build qubit arrays with a high degree of process control. Here, we present progress toward the realization of a 300mm Si/SiGe based spin qubit device in a production environment.  A spin qubit relies on the spin of a single electron in an external magnetic field to encode the two states of the qubit, where spin up vs down represent 0 vs 1.   Spin Qubits are compelling as their appearance and fabrication is similar to conventional CMOS transistors that drive the microelectronics industry.  At the same time, they are roughly one million time smaller than the superconducting qubits that are being pursued by other companies.  In addition, this talk will focus on a key bottleneck to moving beyond today’s few-qubit devices:  the interconnect scheme and control of a large quantum circuit.  Today’s qubits have personalities.  Individual control of each qubit is required.   A small quantum processor today has multiple RF and DC wires per qubit.   This is a brute force approach to wiring and will not scale to the millions of qubits needed for large applications.  At Intel, we have developed customized control chips, optimized for performance at low temperature, with a goal of simplifying wiring and replacing the racks and racks of discrete electrical components.


Jim Clarke is the director of the Quantum Hardware research group within Intel’s Components Research Organization. Jim launched Intel’s Quantum Computing effort in 2015, as well as a research partnership with QuTech (TU Delft and TNO). His group’s primary focus is to use Intel’s process expertise to develop scalable qubit arrays.  In 2018, Jim worked with industry leaders and the Intel policy group to influence the U.S. National Quantum Initiative Act.  Prior to his current role, Jim managed a group focused on interconnect research at advanced technology nodes as well as evaluating new materials and paradigms for interconnect performance. He has co-authored more than 100 papers and has over 50 patents.  Prior to joining Intel in 2001, Jim completed a B.S. in chemistry at Indiana University, a Ph.D. in physical chemistry at Harvard University and a post-doctoral fellowship in physical organic chemistry at ETH, Zürich.   He is a member of IEEE.

Dr. Nir Modiano (modiano@ohsu.edu) from OHSU, is looking to collaborate with a chemist or toxicologist on an effort to understand whether the therapeutic PPS may contribute to inflammatory bowel disease.

“Briefly, PPS is a sulfated polysaccharide that is used as a therapy for interstitial cystitis.  We have found that a few of our IBD patients on PPS improved after stopping the PPS.  In the 1990’s studies of high-dose PPS use for bladder cancer were dose-limited by proctitis, supporting the notion that it could be a causative agent in colitis.  We then noticed a number of patients on it developed multifocal dysplasia, requiring colectomy to prevent progression to malignancy.  Since the number of patients taking PPS is fairly small, we collaborated with Stanford and identified 30 patients with IBD who had been on PPS for >2 years (arbitrarily chosen because we did not want to include patients who had minimal exposure).  Of these, 1 in 3 developed multifocal dysplasia as of time of our study, which is a very high number.  We think this case series supports the hypothesis that PPS may increase the risk of both IBD and colonic dysplasia, though obviously, a small case series is not a definitive study.     

Of note, PPS may share similiarities in chemical structure with DSS, and both are sulfated polysaccharides, though we have not yet had a chemist or toxicologist weigh in on whether the similarities are likely to be relevant.  We’d be interested in gaining perspective from someone with relevant experience in toxicology to help us understand our observations and, perhaps, collaborate on research related to these findings.  One reason I find this so interesting is that it may offer insight into other environmental exposures that may be contributing to the rapid increase in IBD cases we are seeing in the western world, and perhaps, the increased rates of colorectal cancer at younger ages.”

Dear Oregon State Colleagues,

We are pleased to announce the launch of the Research Impact and Advancement Academy on Friday, October 21. This Academy is designed by the new Office for Research Advancement to bolster and enhance the ability for OSU researchers to successfully lead and compete for large collaborative proposals. It will provide a social learning structure where faculty can develop the knowledge, skills, practices, and relationships to successfully lead large transdisciplinary proposals, and execute and manage funded solutions-focused research programs.

In the inaugural year of the Academy, 20 Fellows have been selected in close cooperation with the Deans and Associate Deans for Research. They represent expertise across colleges and a wide range of the research strengths at OSU. The Fellows will enter the Academy for a two-year program starting out with a series of ten workshops for the first year. In these workshops, they will develop mindsets and frameworks for leading large transdisciplinary research efforts and will be provided the tools and practices of leading this type of work. During the Spring term, the Fellows will develop a multi-year plan and proposal for success and pitch for seed funds to pursue those plans. The Academy will be recurring with a new cohort of faculty every academic year.

Integrated into this first Academy cohort will be ten Valley Fellows concentrating on solutions to significant biohealth challenges. The biohealth sciences focuses on human health in a holistic manner, by identifying mechanisms and health risks, with emphasis on optimizing health through both prevention and treatment. Proposal development will be aiming for NIH and other funding opportunities focused on biohealth sciences. The Valley Fellows Program is funded through a generous grant from the Wayne and Gladys Valley Foundation.

Finally, the Office of Research Advancement is rolling out additional workshops and organizing several campus conversations. In total, seven Research Office Campus Conversations (ROCC) and two to three Research Office Lunch and Learn (ROLL) workshop series will be organized each academic year. Topics include ‘Demystifying USDA Funding’, ‘Going for Large Center/Facility Proposals’, ‘Integrating JEDI into Proposal Writing’ and ‘New-to-NIH’. In addition, the Research Office Advancement IGNITE series will bring university-wide communities together around broad research themes that are eminently growing in importance and strength at OSU. Topics this coming year include ‘Public Health and Climate Change’, ‘Water Resilience’ and ‘Renewable Clean Energy’.

Our offices are committed to supporting your success in accomplishing our research mission. Together, all of these new activities are in support of further advancing the research enterprise and scholarship at OSU while increasing the impact of our work in the arenas of both transdisciplinary research and scholarship and use-inspired research, two areas where OSU is extremely well positioned to excel and become leaders.


Edward Feser

Provost and Executive Vice President

Irem Tumer

Vice President for Research


Position            Specialist, Quality Control

Company          Vernal Biosciences

Location           Essex, Vermont

Website            www.vernal.bio


Vernal Biosciences is an mRNA manufacturing and lipid nanoparticle formulation company that is transitioning its research-use-only business and technology to become a cGMP-compliant contract development and manufacturing organization (CDMO).  Vernal’s products are known within the industry to be high purity and useful to all known use cases for mRNA, including vaccines, gene editing and regulation, immuno-oncology, gene replacement therapy, and more.  Vernal’s planned growth, supported by Ampersand Capital and Dynamk Capital, includes a new 23,000 SF facility in Essex Vermont, to manufacture bulk clinical drug products.  Vernal’s investors have an outstanding track record of building successful CDMOs, as the principal investors in and operators of Brammer Bio (now part of ThermoFisher Patheon), CMC Biologics (now AGC Biologics), Arranta Bio, and Vibalogics (both now part of Recipharm).

Job Summary

The Specialist, Quality Control will be responsible for supporting Quality Control functions including but not limited to incoming materials, in-process bulk drug substances, and final drug product release testing, environmental monitoring of cleanroom facilities. He or she partners with manufacturing sciences and technology (MSAT), quality assurance, and operations to support applicable aspects of CDMO work. This individual will also have growth opportunities to learn different facets of the business including manufacturing and different aspects of CQV deliverables.  This individual will also work with establishing the electronic laboratory information management system (LIMS).

Key Areas of Focus

  • Uses Vernal’s quality systems and programs to promote high-quality standards and continuous quality improvement.
  • Train and execute various QC tests, including but not limited to incoming materials, in-process bulk drug substances, and final drug product release testing, environmental monitoring of cleanroom facilities
  • Support establishing and use of LIMS.  
  • Utilize the electronic quality management system (eQMS, Master Control) for writing, reviewing, and training on GMP documents and to document on-the-job training.
  • Ensures compliance with FDA Good Clinical Practice (GCP) and Good Manufacturing Practices (GMP), EU, and ICH guidelines and regulations with respect to job functions at Vernal.
  • Provides back-room support for health authority inspections and customer audits
  • Ensures documentation is compliant with Vernal SOPs, formats, and regulatory requirements (protocols, amendments, etc.)
  • Utilize Vernal’s eQMS and LIMS to ensure QC testing is properly executed.

Essential Duties and Responsibilities

  • Support quality policy, mission, and vision.
  • Execute various QC tests, including but not limited to incoming materials, in-process bulk drug substances, and final drug product release testing, environmental monitoring of cleanroom facilities
  • Support the development and documentation of QC tests under GMP guidelines and Good Documentation Practices.
  • Represent the Quality Control organization in internal discussions.


Professional Experience and Qualifications

  • Bachelor’s degree in a scientific or engineering discipline or equivalent experience required. 
  • 0-5 years in a role familiar with the quality control organization.  
  • GLP/GMP experience in a biotech, pharmaceutical or clinical research organization is beneficial
  • Demonstrated ability to participate in cross-functional teams.
  • Demonstrated ability to work independently, handle multiple tasks simultaneously, and escalate needs to meet critical timelines.
  • Experience or familiarity in quality control laboratory testing or environmental monitoring is a plus.
  • Basic knowledge of GCP, GLP, ICH guidelines, FDA guidelines, and other applicable regulatory requirements.
  • Excellent organizational, verbal, and written communication skills. 
  • Demonstrated ability to problem-solve and learn.

The Department of Chemistry and Chemical Biology at Northeastern University has multiple faculty openings in Boston. 

Tenure-track position in Antibiotic Resistance and Antimicrobials https://northeastern.wd1.myworkdayjobs.com/en-US/careers/details/Open-Rank–Assistant-Associate-Professor—Antibiotic-Resistance-and-Antimicrobials–Chemistry-and-Chemical-Biology_R109460

Tenure-track position in Metabolism in Brain and Body Health https://northeastern.wd1.myworkdayjobs.com/en-US/careers/details/Open-Rank–Assistant-Associate-Professor—Metabolism-in-Brain-and-Body-Health–Chemistry-and-Chemical-Biology_R109692-1

Tenure-track INVEST position, open research area, to give excellent candidates at the earliest stages of their careers the opportunity, resources, and support to establish innovative and impactful research careers. Postdoctoral research experience is not required. https://northeastern.wd1.myworkdayjobs.com/en-US/careers/details/Assistant-Professor—INVEST-Program—College-of-Science_R107522

Tenure-track position in Experimental Biological Physics, possible joint appointment in Chemistry https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Open-Rank–Assistant-Associate-Professor—Experimental-Biological-Physics_R109716

Biotechnology Teaching Professor (full time): The instructor will be responsible for teaching core biotechnology courses (Cell Culture Processes for Biopharmaceutical Production, Molecular Cell Biology for Biotech, and/or Protein Chemistry, Foundations in Biotechnology), and lead one of the defined program concentrations. https://northeastern.wd1.myworkdayjobs.com/en-US/careers/details/Assistant-Associate-Teaching-Professor—Biotechnology-Programs_R109414